Psoriasis does appear capable of contributing to nerve damage, though the relationship is more layered than a simple cause-and-effect. A prospective cohort study found that patients with psoriasis and psoriatic arthritis had a dramatically elevated risk of developing polyneuropathy compared to matched controls, with all confirmed cases showing a pattern of sensory nerve damage starting in the feet and hands.1PubMed. Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study Beyond that, studies have documented reductions in the tiny nerve fibers within psoriatic skin itself, autonomic nervous system dysfunction, elevated blood markers of neural injury, and neuropathic-type pain in a substantial share of patients. The full picture involves the skin, the joints, the immune system, and the nerves talking to each other in ways researchers are still mapping out.
What the Prospective Evidence Shows
The strongest piece of direct evidence comes from a study that followed psoriasis and psoriatic arthritis patients over time and compared them to healthy controls. Nine patients in the psoriasis/psoriatic arthritis group were diagnosed with confirmed polyneuropathy, while none of the controls had it. The polyneuropathy in every case was length-dependent, symmetrical, and mostly sensory, meaning it affected sensation more than movement, and it started farthest from the spine (typically the feet first).1PubMed. Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study The relative risk was strikingly high, around 19 times the risk of controls, though the confidence intervals were wide because the absolute number of cases was small. That means we can say the association is real, but the precise magnitude of the risk is still uncertain.
The researchers noted minimal or no disability from the polyneuropathy in these patients, which is worth emphasizing. This was not a devastating, limb-threatening form of nerve damage. It was subtle enough that many patients may not have realized they had it until formal testing picked it up. That subtlety is part of why the connection between psoriasis and neuropathy has been under-recognized for so long.
Neuropathic Pain Without Obvious Nerve Injury
Even in the absence of diagnosable polyneuropathy, a significant fraction of people with psoriasis and psoriatic arthritis experience pain that behaves like nerve damage. Neuropathic pain has distinct qualities: burning, tingling, shooting sensations, numbness, or pain triggered by a light touch that would not normally hurt. In one study of 64 psoriatic arthritis patients, about a quarter screened positive for likely neuropathic pain, and another fifth fell into the “possible” category.2PubMed Central. Neuropathic-like pain in psoriatic arthritis: evidence of abnormal pain processing A separate cross-sectional study of 114 psoriatic arthritis patients found neuropathic pain in about 24% of them.3PubMed Central. Prevalence of central sensitization and neuropathic pain in patients with psoriatic arthritis: A cross-sectional study
This matters because standard anti-inflammatory painkillers tend to work poorly against neuropathic pain. If a dermatologist or rheumatologist treats a psoriatic arthritis patient’s pain as purely inflammatory and the patient still reports burning or shooting pain, neuropathic mechanisms could be the missing piece. Screening questionnaires designed to detect neuropathic pain, such as the LANSS and PainDETECT, have shown good sensitivity and specificity in psoriatic arthritis patients.4PubMed. Prevalence of peripheral neuropathy in Egyptian psoriatic arthritis patients and its correlation with disease activity The tools exist; the challenge is remembering to use them.
The Nerves Inside Psoriatic Skin
One of the more striking findings in this area involves what happens to the tiny nerve fibers that thread through the outer layers of skin. In psoriatic plaques, three-dimensional imaging has revealed a roughly 74% reduction in nerve fiber length per unit volume compared to healthy skin.5Journal of Investigative Dermatology. 3-Dimensional Optical Clearing and Imaging of Pruritic Atopic Dermatitis and Psoriasis Skin Reveals Downregulation of Epidermal Innervation That is a dramatic loss of the nerve endings responsible for sensation, temperature detection, and itch signaling.
This finding seems paradoxical at first. If the skin has fewer nerve fibers, you might expect psoriatic plaques to be numb. Instead, many patients experience intense itch, burning, or pain in their plaques. The explanation likely involves a combination of factors: the remaining nerve fibers may become hypersensitive, the immune environment in the plaque bathes those fibers in inflammatory signals, and the brain may amplify incoming signals from damaged nerves (a process called central sensitization, discussed below). So the nerves are both reduced in number and malfunctioning, which creates a confusing mix of diminished architecture and heightened sensation.
How Inflammation Drives Nerve Changes
The connection between psoriatic inflammation and nerve damage is not accidental. The immune system and the nervous system are in constant two-way communication, and in psoriasis, that conversation goes badly wrong.
Nerves in the skin release signaling molecules called neuropeptides, including substance P and calcitonin gene-related peptide (CGRP). These neuropeptides can activate immune cells, particularly dendritic cells, which then ramp up the production of inflammatory cytokines that drive psoriatic inflammation.6PubMed Central. Effects of Neuropeptides on Dendritic Cells in the Pathogenesis of Psoriasis Research in animal models has shown that CGRP released from pain-sensing nerve fibers can push dendritic cells to release IL-23, which in turn triggers immune cells to secrete IL-17, one of the central drivers of psoriatic inflammation.7Brain, Behavior, & Immunity – Health. Neuroimmunology of psoriasis: Possible roles for calcitonin gene-related peptide in its pathogenesis
The cycle also runs in the other direction. The inflammatory cytokines that psoriasis produces in abundance, including IL-17A, IL-1β, and TNF-α, can directly disrupt normal nerve cell function. They contribute to pruritus, pain, and the kind of neuroinflammatory sensitization that makes the nervous system overreact to stimuli.8PubMed Central. Neuroimmune Crosstalk in Psoriasis: Mechanisms and Therapeutic Implications So the nerves help cause psoriasis, and psoriasis damages the nerves, and the loop keeps reinforcing itself. This bidirectional relationship is part of why psoriasis can be so persistent and why nerve-related symptoms often track with disease severity.
Central Sensitization and Amplified Pain
Beyond damage to the peripheral nerves in the skin and limbs, psoriasis can alter how the central nervous system processes pain signals. Central sensitization is a state where the spinal cord and brain become hyperexcitable, turning up the volume on pain signals so that even mild stimuli register as painful. In one study of 194 patients with chronic plaque psoriasis, about 10% had scores above the clinical threshold for significant central sensitization, while 30% exceeded the milder threshold. Patients who also had psoriatic arthritis were more likely to show central sensitization than those with skin-only psoriasis.9PubMed Central. Central Pain Sensitization in Patients with Chronic Plaque Psoriasis
Another study put the numbers even higher: 43% of psoriatic arthritis patients scored above the threshold for central sensitization.3PubMed Central. Prevalence of central sensitization and neuropathic pain in patients with psoriatic arthritis: A cross-sectional study The variation between studies likely reflects differences in patient populations and how sick those patients were, but the consistent finding is that a meaningful proportion of psoriasis patients have pain amplification happening at the level of the brain and spinal cord. That amplification can persist even when the skin and joints look relatively calm, which helps explain why some patients continue to report significant pain despite apparently well-controlled disease.
The Autonomic Nervous System Gets Involved Too
Nerve damage in psoriasis is not limited to the sensory system. The autonomic nervous system, the network that controls heart rate, blood pressure, sweating, and digestion without your conscious input, also shows signs of impairment.
In a study of psoriatic arthritis patients, half had abnormal results on at least two tests of autonomic heart function, and about 38% showed moderate dysfunction in sweat gland regulation.10PubMed. Autonomic dysfunction in psoriatic arthritis Separately, psoriasis patients showed impaired heart rate recovery after exercise, which is a well-established marker of autonomic dysfunction and a predictor of cardiovascular risk.11PubMed Central. Impaired heart rate recovery indices in psoriasis patients A study examining cardiac autonomic function found that psoriasis patients had deteriorated autonomic control even without metabolic syndrome, suggesting the autonomic impairment was linked to psoriasis itself rather than to commonly co-occurring metabolic problems like diabetes or obesity.12PubMed. Cardiac and Sudomotor Autonomic Function in Subjects with Psoriasis With and Without Metabolic Syndrome
This is relevant beyond the nerves themselves. Autonomic dysfunction may be one of the mechanisms behind the elevated cardiovascular disease risk that psoriasis patients face. When the autonomic nervous system fails to properly regulate heart rate variability and blood vessel tone, the heart is more vulnerable to arrhythmias and other problems. It is another reminder that psoriasis is a systemic inflammatory condition, not merely a skin disease.
Carpal Tunnel Syndrome in Psoriatic Arthritis
Nerve damage does not always stem from inflammation acting directly on nerve fibers. In psoriatic arthritis, swelling and structural changes around joints can physically compress nerves. Carpal tunnel syndrome, where the median nerve gets squeezed as it passes through the wrist, was found in about 31% of psoriatic arthritis patients in one study, compared to zero in the control group. Imaging confirmed that the median nerve was measurably enlarged in the psoriatic arthritis patients, indicating physical compression.13Journal of Rheumatic Diseases. Carpal Tunnel Syndrome in Patients with Psoriatic Arthritis: Ultrasonography and Magnetic Resonance Imaging Findings
If you have psoriatic arthritis and notice numbness or tingling in your thumb, index, and middle fingers, particularly at night, carpal tunnel syndrome is worth raising with your doctor. It is a treatable condition, and catching it early can prevent the nerve damage from becoming permanent.
Blood Markers Hint at Broader Neural Injury
Researchers have looked at blood biomarkers of nerve and brain cell damage in psoriasis patients and found elevated levels of neurofilament light chain (NFL) and tau protein. Both of these are structural proteins that leak into the bloodstream when nerve cells are damaged. In one study, psoriasis patients had roughly three times the NFL levels of healthy controls, and their tau levels were significantly elevated too. Both markers correlated with disease severity: more severe psoriasis was associated with higher levels of these neural damage markers.14PubMed Central. A preliminary study about neurofilament light chain and tau protein levels in psoriasis: Correlation with disease severity
This is a preliminary finding and should be interpreted cautiously. NFL and tau are not specific to any one type of nerve injury, and they can be elevated in many inflammatory conditions. But the correlation with psoriasis severity is intriguing because it suggests that systemic inflammation from psoriasis may be causing low-grade nerve cell injury body-wide, not just in the skin or joints. It also opens the door to using blood tests, rather than painful nerve biopsies, to track whether treatment is protecting the nervous system.
When the Treatment Itself Poses a Risk
An important wrinkle in the psoriasis-and-nerves story is that some psoriasis treatments can themselves cause neurological complications. Biologic therapies targeting TNF-alpha, which are widely used for moderate-to-severe psoriasis and psoriatic arthritis, have been linked to rare but serious neurological side effects. These can include demyelinating disorders, where the insulating sheath around nerve fibers breaks down, and other forms of peripheral neuropathy. The key recommendation from researchers is that patients on anti-TNF biologics should be monitored for neurological symptoms, and if they develop, stopping the medication early can improve the chances of recovery.15PubMed Central. Neurological Complications of Biological Treatment of Psoriasis
This creates a clinical balancing act. The same biologics that effectively shut down the inflammatory cascade driving psoriasis and potentially protecting nerves from inflammation-related damage can, in rare cases, trigger nerve damage through a different mechanism. If you develop new numbness, weakness, or tingling after starting a biologic, report it promptly. In most cases the benefit of the medication far outweighs this rare risk, but the risk is real enough to warrant awareness.
How Neuropathic Pain Affects Daily Life
The practical consequences of nerve involvement in psoriasis extend well beyond the physical sensation of pain. Psoriatic arthritis patients with neuropathic pain have significantly worse sleep quality, more fatigue, and lower quality of life compared to those without it. In one study, the correlation between neuropathic pain scores and quality of life was strong, and the links to sleep disruption and fatigue were moderate but consistent.16Annals of the Rheumatic Diseases. The relationship between neuropathic pain and disease activity, sleep, fatigue, quality of life in patients with psoriatic arthritis Interestingly, the study found no significant difference in standard measures of disease activity between the neuropathic pain group and the non-neuropathic group, meaning the neuropathic component was contributing to misery independently of how inflamed the joints appeared.
This disconnect between disease activity scores and patient-reported suffering is a recurring theme in the literature and a source of real frustration for patients. You can have joints that look fine on imaging and blood tests that look reasonable, yet still experience burning, shooting pain, terrible sleep, and crushing fatigue because the nervous system has been altered. Recognizing neuropathic pain as a distinct contributor, rather than lumping it under “inflammation,” is important for getting the right treatment.
The Psoriasis and Multiple Sclerosis Question
Because both psoriasis and multiple sclerosis involve the immune system attacking the body’s own tissues, patients sometimes worry about whether having one increases the risk of the other. The honest answer is that the evidence remains limited and conflicting. A narrative review of the available literature described the relationship between psoriasis and multiple sclerosis as “obscure,” with studies pointing in different directions.17PubMed Central. A narrative review of psoriasis and multiple sclerosis: links and risks Both diseases involve dysregulated immune responses, but sharing an immune pathway does not necessarily mean one condition causes or predicts the other. The overlap in immune mechanisms is real; the clinical overlap is unproven.
This is worth knowing mainly so you do not panic if you come across a headline about the two diseases being linked. If you have psoriasis and develop symptoms that suggest central nervous system involvement, like vision changes, coordination problems, or muscle weakness on one side of the body, those deserve urgent medical attention regardless of whether a formal statistical link to psoriasis exists. But having psoriasis does not mean you should expect to develop MS.
Separating Psoriatic Nerve Damage from Other Causes
One challenge in this field is teasing apart what psoriasis itself does to the nerves from what commonly co-occurring conditions do. Psoriasis patients have elevated rates of diabetes, metabolic syndrome, and obesity, all of which are well-known causes of peripheral neuropathy on their own. When a psoriasis patient shows up with numbness in their feet, the first instinct is often to check their blood sugar. And that is appropriate, because diabetic neuropathy is far more common than psoriasis-related neuropathy.
But the studies discussed here took steps to control for metabolic confounders, and many found that nerve-related abnormalities persisted even in psoriasis patients who did not have diabetes or metabolic syndrome. The cardiac autonomic dysfunction study specifically showed impaired autonomic function independent of metabolic syndrome.12PubMed. Cardiac and Sudomotor Autonomic Function in Subjects with Psoriasis With and Without Metabolic Syndrome This does not mean metabolic factors are irrelevant; it means psoriasis likely adds its own independent contribution to nerve damage, stacking on top of whatever metabolic risk factors are present. For patients with both psoriasis and diabetes, the risk could compound.
If you have psoriasis and are experiencing unexplained tingling, burning, numbness, or pain that does not match the location of your plaques or joints, it is worth asking your doctor to investigate further. The tools for detecting neuropathic pain are simple questionnaires, and nerve conduction studies or skin biopsies can confirm the diagnosis if needed. The awareness that psoriasis itself might be part of the problem is still filtering into routine clinical practice, so bringing it up yourself can sometimes be the difference between getting the right assessment and having symptoms dismissed.